Jiahui Zhang1,2, Changming Zhang3,4, Erzhi Gao3, Qing Zhou1,2. 1. Life Sciences Institute, The Key Laboratory of Biosystems Homeostasis & Protection of Ministry of Education, Zhejiang University, Hangzhou, China. 2. Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China. 3. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. 4. Zhejiang University School of Medicine, Hangzhou, China.
Abstract
BACKGROUND: At least 10% of adults and most of the children who receive renal replacement therapy have inherited kidney diseases. These disorders substantially decrease their life quality and have a large effect on the health-care system. Multisystem complications, with typical challenges for rare disorders, including variable phenotypes and fragmented clinical and biological data, make genetic diagnosis of inherited kidney disorders difficult. In current clinical practice, genetic diagnosis is important for clinical management, estimating disease development, and applying personal treatment for patients. SUMMARY: Inherited kidney diseases comprise hundreds of different disorders. Here, we have summarized various monogenic kidney disorders. These disorders are caused by mutations in genes coding for a wide range of proteins including receptors, channels/transporters, enzymes, transcription factors, and structural components that might also have a role in extrarenal organs (bone, eyes, brain, skin, ear, etc.). With the development of next-generation sequencing technologies, genetic testing and analysis become more accessible, promoting our understanding of the pathophysiologic mechanisms of inherited kidney diseases. However, challenges exist in interpreting the significance of genetic variants and translating them to guide clinical managements. Alport syndrome is chosen as an example to introduce the practical application of genetic testing and diagnosis on inherited kidney diseases, considering its clinical features, genetic backgrounds, and genetic testing for making a genetic diagnosis. KEY MESSAGES: Recent advances in genomics have highlighted the complexity of Mendelian disorders, which is due to allelic heterogeneity (distinct mutations in the same gene produce distinct phenotypes), locus heterogeneity (mutations in distinct genes result in similar phenotypes), reduced penetrance, variable expressivity, modifier genes, and/or environmental factors. Implementation of precision medicine in clinical nephrology can improve the clinical diagnostic rate and treatment efficiency of kidney diseases, which requires a good understanding of genetics for nephrologists.
BACKGROUND: At least 10% of adults and most of the children who receive renal replacement therapy have inherited kidney diseases. These disorders substantially decrease their life quality and have a large effect on the health-care system. Multisystem complications, with typical challenges for rare disorders, including variable phenotypes and fragmented clinical and biological data, make genetic diagnosis of inherited kidney disorders difficult. In current clinical practice, genetic diagnosis is important for clinical management, estimating disease development, and applying personal treatment for patients. SUMMARY: Inherited kidney diseases comprise hundreds of different disorders. Here, we have summarized various monogenic kidney disorders. These disorders are caused by mutations in genes coding for a wide range of proteins including receptors, channels/transporters, enzymes, transcription factors, and structural components that might also have a role in extrarenal organs (bone, eyes, brain, skin, ear, etc.). With the development of next-generation sequencing technologies, genetic testing and analysis become more accessible, promoting our understanding of the pathophysiologic mechanisms of inherited kidney diseases. However, challenges exist in interpreting the significance of genetic variants and translating them to guide clinical managements. Alport syndrome is chosen as an example to introduce the practical application of genetic testing and diagnosis on inherited kidney diseases, considering its clinical features, genetic backgrounds, and genetic testing for making a genetic diagnosis. KEY MESSAGES: Recent advances in genomics have highlighted the complexity of Mendelian disorders, which is due to allelic heterogeneity (distinct mutations in the same gene produce distinct phenotypes), locus heterogeneity (mutations in distinct genes result in similar phenotypes), reduced penetrance, variable expressivity, modifier genes, and/or environmental factors. Implementation of precision medicine in clinical nephrology can improve the clinical diagnostic rate and treatment efficiency of kidney diseases, which requires a good understanding of genetics for nephrologists.
Authors: J Thoene; R Lemons; Y Anikster; J Mullet; K Paelicke; C Lucero; W Gahl; J Schneider; S G Shu; H T Campbell Journal: Mol Genet Metab Date: 1999-08 Impact factor: 4.797
Authors: Liyun Sang; Julie J Miller; Kevin C Corbit; Rachel H Giles; Matthew J Brauer; Edgar A Otto; Lisa M Baye; Xiaohui Wen; Suzie J Scales; Mandy Kwong; Erik G Huntzicker; Mindan K Sfakianos; Wendy Sandoval; J Fernando Bazan; Priya Kulkarni; Francesc R Garcia-Gonzalo; Allen D Seol; John F O'Toole; Susanne Held; Heiko M Reutter; William S Lane; Muhammad Arshad Rafiq; Abdul Noor; Muhammad Ansar; Akella Radha Rama Devi; Val C Sheffield; Diane C Slusarski; John B Vincent; Daniel A Doherty; Friedhelm Hildebrandt; Jeremy F Reiter; Peter K Jackson Journal: Cell Date: 2011-05-13 Impact factor: 41.582
Authors: P Martin; N Heiskari; J Zhou; A Leinonen; T Tumelius; J M Hertz; D Barker; M Gregory; C Atkin; U Styrkarsdottir; H Neumann; J Springate; T Shows; E Pettersson; K Tryggvason Journal: J Am Soc Nephrol Date: 1998-12 Impact factor: 10.121
Authors: Sandro Rossetti; Vickie J Kubly; Mark B Consugar; Katharina Hopp; Sushmita Roy; Sharon W Horsley; Dominique Chauveau; Lesley Rees; T Martin Barratt; William G van't Hoff; Patrick Niaudet; W Patrick Niaudet; Vicente E Torres; Peter C Harris Journal: Kidney Int Date: 2009-01-21 Impact factor: 10.612
Authors: Maria Antonietta Mencarelli; Laurence Heidet; Helen Storey; Michel van Geel; Bertrand Knebelmann; Chiara Fallerini; Nunzia Miglietti; Maria Fatima Antonucci; Francesco Cetta; John A Sayer; Arthur van den Wijngaard; Shu Yau; Francesca Mari; Mirella Bruttini; Francesca Ariani; Karin Dahan; Bert Smeets; Corinne Antignac; Frances Flinter; Alessandra Renieri Journal: J Med Genet Date: 2015-01-09 Impact factor: 6.318